<?xml version="1.0" encoding="UTF-8"?><ns2:project xmlns:ns1="http://gtr.rcuk.ac.uk/gtr/api" xmlns:ns2="http://gtr.rcuk.ac.uk/gtr/api/project" xmlns:ns3="http://gtr.rcuk.ac.uk/gtr/api/fund" xmlns:ns4="http://gtr.rcuk.ac.uk/gtr/api/person" xmlns:ns5="http://gtr.rcuk.ac.uk/gtr/api/project/outcome" xmlns:ns6="http://gtr.rcuk.ac.uk/gtr/api/organisation" ns1:created="2026-06-03T15:52:43Z" ns1:href="http://gtr.ukri.org/gtr/api/projects/C57AA94D-8059-4353-8C3B-0B4915520CD3" ns1:id="C57AA94D-8059-4353-8C3B-0B4915520CD3"><ns1:links><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/persons/61756534-BEF4-4D62-96D1-D2EE0856FCBD" ns1:rel="PM_PER"/><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/90E361E7-0645-4DD9-8318-1F7ACD3EB3B6" ns1:rel="LEAD_ORG"/><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/E8D7C952-3C5D-4565-A059-FA6B5E112E35" ns1:rel="PARTICIPANT_ORG"/><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/04758582-53CF-4876-AB65-D614428F34B6" ns1:rel="PARTICIPANT_ORG"/><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/D5BE61AF-C3D9-4EA6-B3CA-126253420776" ns1:rel="PARTICIPANT_ORG"/><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/90E361E7-0645-4DD9-8318-1F7ACD3EB3B6" ns1:rel="PARTICIPANT_ORG"/><ns1:link ns1:end="2017-01-31T00:00:00Z" ns1:href="http://gtr.ukri.org/gtr/api/funds/DB7F5FAA-EBB3-4653-B9D0-77C0532D198C" ns1:rel="FUND" ns1:start="2013-11-01T00:00:00Z"/></ns1:links><ns2:identifiers><ns2:identifier ns2:type="RCUK">101555</ns2:identifier></ns2:identifiers><ns2:title>Translation of Bovine Tuberculosis biomarkers to the Point of care setting.</ns2:title><ns2:status>Closed</ns2:status><ns2:grantCategory>Collaborative R&amp;D</ns2:grantCategory><ns2:leadFunder>Innovate UK</ns2:leadFunder><ns2:abstractText>Bovine tuberculosis (M. bovis) remains a major disease of cattle in the United Kingdom. The diagnosis and management of infected herds represents a significant burden to the UK taxpayer as bovine tuberculosis is a notifiable disease. Current testing regimens are laborious and time consuming, with blood samples needing to be transported to centralised testing facilities, where analysis and the reporting of findings can take a number of days. This makes rapid responses to infection difficult and costly. Within this project we propose the development and validation of a number of blood based biological markers which will subsequently be incorporated into a point of care device that can be used to rapidly obtain test results in the field. Such a device would have mobile phone/internet and global positioning system capabilities allowing results of tests conducted at a remote location to be uploaded rapidly to websites that communicate with regulatory authorities and facilitate herd management.</ns2:abstractText></ns2:project>